E. GERALD KAY - 30 Jun 2023 Form 5 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Executive Chairman & President, Director, 10%+ Owner
Signature
/s/ Christina Kay
Issuer symbol
INBP
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
5
Filing time
16 Nov 2023, 16:13:09 UTC
Previous filing
10 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Will/Inheritance $0 -4,299,533 -100% $0.000000* 0 20 Mar 2023 Direct
transaction INBP Common Stock Will/Inheritance $0 -853,022 -100% $0.000000* 0 20 Mar 2023 As sole member of LLC or Trustee of Trusts F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -150,000 -100% $0.000000* 0 20 Mar 2023 Common Stock 150,000 $0.2300 Direct F2, F3
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -100,000 -100% $0.000000* 0 20 Mar 2023 Common Stock 100,000 $0.7200 Direct F2, F3, F4
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -65,000 -100% $0.000000* 0 20 Mar 2023 Common Stock 65,000 $1.04 Direct F2, F3, F5
transaction INBP Stock Option (right to buy) Will/Inheritance $0 -100,000 -100% $0.000000* 0 20 Mar 2023 Common Stock 100,000 $0.4500 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

E. GERALD KAY is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee.
F2 The option vested over three years beginning of the first year anniversary noted herein.
F3 Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death.
F4 Includes 33,333 shares that were not vested at the time of the Reporting Person's passing.
F5 Includes 43,333 shares that were not vested at the time of the Reporting Person's passing.
F6 None of the Options were vested at the time of passing of the Reporting Person.